The ROE as of September 2024 (TTM) for Timber Pharmaceuticals, Inc. (TMBR) is -520.78%

According to Timber Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -520.78%. This represents a change of 657.29% compared to the average of -68.77% of the last 4 quarters.

Timber Pharmaceuticals, Inc. (TMBR) Historical ROE (quarterly & annually)

How has TMBR ROE performed in the past?

The mean historical ROE of Timber Pharmaceuticals, Inc. over the last ten years is -326.65%. The current -520.78% ROE has changed 59.43% with respect to the historical average. Over the past ten years (40 quarters), TMBR's ROE was at its highest in in the June 2020 quarter at 381.79%. The ROE was at its lowest in in the January 2020 quarter at -1101.77%.

Timber Pharmaceuticals, Inc. (TMBR) ROE by Quarter and Year

Discovering the peaks and valleys of Timber Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Timber Pharmaceuticals, Inc. (TMBR) Average ROE

How has TMBR ROE performed in the past?

The current ROE of Timber Pharmaceuticals, Inc. (TMBR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Timber Pharmaceuticals, Inc. (TMBR) ROE vs. Peers

How is TMBR’s ROE compared to its peers?

Timber Pharmaceuticals, Inc.’s ROE is greater than Salarius Pharmaceuticals, Inc. (-148.64%), greater than Artelo Biosciences, Inc. (-37.69%), greater than Nutriband Inc. (-76.31%), greater than Aileron Therapeutics, Inc. (-47.94%), greater than Artelo Biosciences, Inc. (-37.69%), greater than Histogen Inc. (-108.33%), greater than Curis, Inc. (-328.39%), greater than First Wave BioPharma, Inc. (-28.76%), greater than SAB Biotherapeutics, Inc. (-94.04%), less than Vaccinex, Inc. (1.11%), greater than GeoVax Labs, Inc. (-852.58%), greater than TRACON Pharmaceuticals, Inc. (-237.65%), greater than Entera Bio Ltd. (-100.37%), greater than Tempest Therapeutics, Inc. (-201.10%), less than Better Therapeutics, Inc. (223.92%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Senti Biosciences, Inc. (-91.09%), greater than Hillstream BioPharma, Inc. (-47249.59%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%),

Build a custom stock screener for Timber Pharmaceuticals, Inc. (TMBR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Timber Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Timber Pharmaceuticals, Inc. (TMBR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Timber Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.